Novavax Inc.'s vaccine was cleared by European regulators on Monday, becoming the first Covid-19 shot of its kind in the region. Novavax CEO Stanley Erck discusses the vaccines' approval, distribution plans, and testing for efficacy against the omicron variant on "Bloomberg Markets: European Close"
-
Categories
- Everything (14437)
- Blockchain News (2013)
- Blockchain Apps (34)
- Crypto Currencies (247)
- White Papers (26)
- ICO (124)
- Use Cases (416)
- Conference and Seminars (15)
- Courses (19)
- Jobs and Talent (85)
- Events (35)
- Training and Lectures (120)
- Developers (16)
- Token (17)
- Research and Reports (614)
- Regulation (33)
- Service Providers (36)
- Wallets (25)
- Video (8786)
- Investors (27)
- Listen (62)
- Press Release (31)
- Tasks (18)
- 4IR Company (34)
- Defi (20)
- NFT (1)
- DAONFT
- Search BC
- About BC